While depression is relatively common in pregnancy and we have data to support the reproductive safety of many different antidepressants, many women are reluctant to use antidepressant medications during pregnancy. Because untreated depression in [...]
Over the last few years, the medical community has been using the term perinatal mood and anxiety disorders (PMADs) to describe the spectrum of psychological symptoms women may experience during pregnancy or the postpartum period. [...]
While we have heard a lot about brexanolone, marketed by Sage Therapeutics as Zulresso, for the treatment of postpartum depression, an oral version of this novel antidepressant – SAGE 217 or zuranolone – has been [...]
Every Wednesday, we have the pleasure of holding virtual rounds with other clinicians to discuss important topics in reproductive psychiatry. So many great questions! Last week, one of our participants asked about using light therapy [...]
Previous research has shown that higher levels of depressive symptoms during pregnancy may be associated with lower levels of maternal-fetal attachment (MFA). Other studies have indicated that poor MFA is a significant predictor of worse [...]
A recent study from Japan uses a retrospective review of medical records to estimate the prevalence of suicide attempts among pregnant and postpartum women.
Perinatal mood and anxiety disorders (PMADs) including prenatal depression (PND) and postpartum depression (PPD) can have a profound adverse impact on the well-being of mothers, newborns, and entire families. It is estimated that 20%-25% [...]
In the Boston area, the number of people hospitalized for COVID-19 is steadily decreasing. This is obviously happy news and a long-awaited reason to celebrate; however, we continue to be concerned about the mental [...]
Rommel and colleagues present a systematic review examining the long-term effects of prenatal exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes in children 4 years of age or older.Â
Over the last decade, various studies have examined the risk of obstetric complications in women using antidepressants during pregnancy.  Preeclampsia:  Some studies have suggested that pregnant women taking SSRI antidepressants may be at higher [...]
